Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1996-07-16
1997-12-09
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
A61K 31135
Patent
active
056961685
ABSTRACT:
A group of propanamines, norepinephrine uptake inhibitors, are used to treat attention-deficit/hyperactivity disorder.
REFERENCES:
patent: 4956388 (1990-09-01), Robertson et al.
Green, Wayne H., Child Adolesc. Psychi. Clinics North America, 1, 449-465 (1992).
Spencer, et al., J. Am. Acad. Child Adolesc. Psychiatry, 32, 205-210 (1993).
Biederman, et al., J. Am. Acad. Child Adolesc. Psychiatry, 28, 777-784 (1989).
Wilens, et al., J. Am. Acad. Child Adolesc. Psychiatry, 32, 343-349 (1993).
Biederman, et al., Am. J. Psychiatry, 148, 564-577.
Biederman, et al., Am. J. Psychiatry, 150, 1792-1798 (1993).
Gehlert, et al., Neuroscience Ltrs., 157, 203-206 (1993).
Wong, et al., J. Pharmacol. Exp. Therap., 222, 61-65 (1982).
Wong, David T., and Bymaster, Frank P., Research Comm. Chem. Pathol. Pharmacol., 15, 221-231 (1976).
Fuller, Ray W., and Wong, David T., J. Clin. Psychopharmacol., 7, 6 Suppl., 36S-43S (1987).
Wong, et al., Neuropsychopharmacology, 8, 23-33 (1993).
Fuller, et al., J. Pharmacol. Exp. Ther., 269, 132-136 (1994).
Ikeda, et al., Neuropsychopharmacology, 10, Suppl. Pt. 1, 650S (1994).
Zerbe, et al., J. Pharmacol. Exp. Ther., 232, 139-143 (1985).
Chumpradit, et al., J. Med. Chem., 35, 4492-4497 (1992).
Oberlender, et al., J. Pharm. Pharmacol., 39, 1055-1056 (1987).
Steinberg, et al., Am. J. Psychiatry, 142, 1517-1518 (1985).
Chouinard, et al., Psychopharmacology, 83, 126-128 (1984).
Chouinard, et al., Psychopharmacol. Bull., 21, 73-76 (1985).
Farid, et al., J. Clin. Pharmacol., 25, 296-301 (1985).
Fuller, et al., Res. Comm. Chem. Pathol. Pharmacol., 41, 169-172 (1983).
Zhang, et al., J. Pharmacol. Exp. Ther., 259, 1088-1093 (1991).
Springer, et al., J. Urology, 152, 515-519 (1994).
Terry, et al., J. Pharmacol. Exp. Ther., 270, 1041-1048 (1994).
Johanson, et al., J. Pharmacol. Exp. Ther., 267, 1-8 (1993).
Keshavarzian, et al., Gastroenterology, 98, 554-560 (1990).
Cusack, et al., Psychopharmacology, 114, 559-565 (1994).
Ryan, Neal D., J. Child Adolesc. Psychopharmacol., 1, 21-31 (1990).
"Imipramine", Physicians' Desk Ref., 1070-1074 (1993).
"Desipramine", Physicians' Desk Ref., 1389-1390 (1993).
"Nortriptyline", Physicians' Desk Ref., 2115-2116 (1993).
"Amitriptyline", Physicians' Desk Ref., 2372-2374 (1993).
"Clomipramine", Physicians' Desk Ref., 671-675 (1993).
"Bupropion", Physicians' Desk Ref., 842-844 (1993).
"Fluoxetine", Physicians' Desk Ref., 877-880 (1994).
"Chlorpromazine", Physicians' Desk Ref., 2327-2330 (1993).
"Clonidine", Physicians' Desk Ref., 612-614 (1994).
The Medical Letter, 32, p. 53, Jun. 1990.
Riddle, et al., J. Am. Acad. Child Adolesc. Psychiatry, 30; 1, 104-108 (1991).
Geller, Barbara, J. Am. Acad. Child Adolesc. Psychiatry, 30:4, 682-684 (1991).
Wilens, et al., J. Am. Acad. Child Adolesc. Psychiatry, 31:4, 691-698 (1992).
Biederman, et al., J. Am. Acad. Child Adolesc. Psychiatry, 32:4, 805-813 (1993).
Walsh, et al., J. Am. Acad. Child Adolesc. Psychiatry, 33:2, 191-197 (1994).
"Letters to the Editor", J. Am. Acad. Child Adolesc. Psychiatry, 33:4, 588-590 (1994).
"Letters to the Editor", J. Am. Acad. Child Adolesc. Psychiatry, 34:2, 125-126 (1995).
Werry, John S., J. Am. Acad. Child Adolesc. Psychiatry, 34:9, 1239-1248 (1995).
Leonard, et al., J. Am. Acad. Child Adolesc. Psychiatry, 34:11, 1460-1468 (1995).
Rudorfer, et al., J. Clin. Psychopharmacol., 11, 22-27 (1991).
Delgado, et al., Psychopharm. Bull., 29, 389-396 (1993).
Asnis, et al., Am. J. Psychiatry, 152, 31-36 (1995).
Delgado, et al., Arch. Gen. Psychiatry, 51, 865-874 (1994).
Benkert, et al., International Clin. Psychopharma., 8 Suppl. 1, 3-14 (1993).
Hudson, et al., Am. J. Psychiatry, 147, 552-564 (1990).
Kihara, et al., J. Pharmacol. Exp. Ther., 272, 177-183 (1995).
Wong, D.T., and Shaw, W.N., Soc. Neuroscience Abstracts, 19, 1239 (1993).
Murphy, et al., Soc. Neuroscience Abstracts, 15, 58 (1989).
Heiligenstein John Harrison
Laguzza Bennett Coleman
Paul Steven Marc
Tollefson Gary Dennis
Boone David E.
Eli Lilly and Company
Jordan Kimberly
Titus Robert D.
LandOfFree
Treatment of attention-deficit/hyperactivity disorder does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of attention-deficit/hyperactivity disorder, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of attention-deficit/hyperactivity disorder will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1608290